• Expert Rev Anticancer Ther · Dec 2016

    Editorial

    Optimal design and endpoint of clinical trials using immune checkpoint blocking agents.

    • Bhumsuk Keam, Hun Jung, and Byung Ho Nam.
    • a Department of Internal Medicine , Seoul National University Hospital , Seoul , Republic of Korea.
    • Expert Rev Anticancer Ther. 2016 Dec 1; 16 (12): 1217-1218.

    no abstract available

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…